Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Chronic pelvic pain (\>6 months) perceived to be related to the urinary bladder and accompanied by urinary symptoms such as frequent urination during the day and/or night, and/or urgency to void~* Total score of 8 or greater on the O'Leary-Sant Interstitial Cystitis Symptom Index (ICSI)~* The mean of the average pain intensity scores at screening phase \>=5 (on a scale of 0 to 10)~* Medically stable~Exclusion Criteria:~* Urinary culture is positive for a urinary tract infection; Recent invasive therapy to the bladder~* History or current conditions indicating that the bladder pain can be caused by diagnoses other than IC/PBS (eg, pain caused by a confirmed or suspected neoplasm)~* History of malignancy within the past 2 years, with the exception of basal cell carcinoma that has been successfully treated~* Women who are pregnant or breast-feeding~* A body mass index (BMI) of \>39 kg/m2

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- JNJ-42160443 (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).